Welcome to our dedicated page for Piper Sandler Co`S SEC filings (Ticker: PIPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Piper Sandler Companies (NYSE: PIPR) SEC filings page on Stock Titan brings together the firm’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As an investment bank and institutional securities firm, Piper Sandler uses SEC filings to report its financial results, describe its operations and comply with ongoing reporting obligations.
Recent Form 8-K filings for Piper Sandler reference Item 2.02 – Results of Operations and Financial Condition, noting the release of financial results for specific fiscal quarters and directing readers to accompanying press releases furnished as exhibits. These current reports complement the firm’s earnings announcements and conference calls, providing an official record of quarterly performance.
On this page, you can access Piper Sandler’s 8-K current reports and, where available, annual reports on Form 10-K, quarterly reports on Form 10-Q, and other relevant filings. Stock Titan’s AI features are designed to highlight key sections, explain technical language and surface important points about advisory and capital markets activities, segment performance and risk disclosures as presented by the company in its filings.
For users interested in governance and ownership information, this page also serves as a starting point to locate proxy materials and insider transaction reports such as Form 4, when filed. Real-time updates from EDGAR combined with AI-generated overviews can help investors and researchers quickly understand what Piper Sandler reports in each document, without reading every page in detail.
Brian R. Sterling, a director of Piper Sandler Companies (PIPR), reported an acquisition on 09/12/2025 of 25,371 shares of common stock delivered under the directors' deferred compensation plan. The transaction shows a price of $0, reflecting that these are dividend-equivalent phantom shares that were deemed reinvested into additional phantom stock. The filing indicates the 25,371 phantom shares are held directly and will be payable in an equal number of common shares on the last day of the year in which Mr. Sterling's service as a director terminates.
Philip E. Soran, a director of Piper Sandler Companies (PIPR), reported an acquisition of 39 shares on 09/12/2025 at no cash price, increasing his beneficial holding to 19,742 shares. The filing shows the shares result from dividend equivalents reinvested as phantom stock under the directors' deferred compensation plan; those phantom shares convert to common stock in an equal number when the director's service ends. The transaction was signed on behalf of Mr. Soran on 09/15/2025.
Mitchell Robbin, a director of Piper Sandler Companies (PIPR), received additional phantom common stock shares through dividend equivalents that were deemed reinvested on 09/12/2025. The reported non-derivative transaction shows 7(1) phantom shares acquired at $0, increasing the reporting person's beneficial ownership to 3,384 shares. The filing explains these phantom shares accrue under the directors' deferred compensation plan and are payable in an equal number of common shares on the last day of the year in which the director's service terminates.
Piper Sandler Companies (PIPR) director Victoria M. Holt reported an acquisition of 7,325 shares of common stock on 09/12/2025. The Form 4 shows the shares were issued at no cash cost (Price $0) under a director deferred compensation arrangement: dividend equivalents on phantom stock are deemed reinvested into additional phantom shares that accrue to her account and convert to common stock when her director service ends. The filing was signed on 09/15/2025 and reflects routine, non-cash compensation-related share accrual rather than an open-market purchase or sale.
Ann C. Gallo, a director of Piper Sandler Companies (PIPR), reported a transaction dated 09/12/2025 that increased her beneficial holdings to 1,198 shares of common stock equivalent. The Form 4 shows a transaction coded A with a price of $0, and an explanation that dividend equivalents on phantom stock were reinvested into additional phantom shares under the directors' deferred compensation plan. Those phantom shares are payable in an equal number of common shares on the last day of the year in which the reporting person’s service as a director terminates. The filing was signed on behalf of Ms. Gallo by James Grant on 09/15/2025.
Piper Sandler Companies (PIPR) submitted a Form 144 notifying the proposed sale of 850 common shares through Charles Schwab, with an aggregate market value of $285,370. The filing reports 17,690,540 shares outstanding and an approximate sale date of 08/12/2025.
The securities were acquired on 05/15/2020 by restricted stock lapse from Piper Sandler Companies and were received as equity compensation. The filer reports Nothing to Report for any sales in the past three months and includes the standard representation that no undisclosed material adverse information is known.
Piper Sandler Companies (PIPR) filed a Form 144 reporting a proposed sale of 2,000 common shares through Charles Schwab & Co., Inc. on the NYSE, with an approximate sale date of 08/11/2025 and an aggregate market value of $645,378.00. The filing lists 17,690,540 shares outstanding and specifies this block for sale.
The filing shows the shares were acquired as equity compensation: 113 shares vested on 02/16/2020, 554 shares vested on 02/16/2024, and 1,333 shares vested on 02/26/2024, all from Piper Sandler Companies. The filer reports nothing to report for securities sold in the past three months.
This Form 4 discloses that John W. Geelan, identified as an officer (General Counsel) of Piper Sandler Companies (PIPR), reported sales of company common stock on 08/11/2025. The filing lists two non-derivative sale transactions totaling 2,000 shares: 366 shares sold at a weighted average price of $321.46 (range $321.23–$321.67) and 1,634 shares sold at a weighted average price of $322.96 (range $322.82–$323.265).
After these transactions the report shows beneficial ownership of 14,279 shares following the first reported sale and 12,645 shares following the second. No derivative transactions are reported. The filer offers to provide per-transaction quantities at specific prices upon request.